ClinicalTrials.gg

Program

PRA-216

A development code. Also written as “Active PRA-216”.

Its studies are mostly in Pulmonary Disease, Chronic Obstructive · Dermatitis, Atopic · Asthma, led by Prana Therapies.

Furthest: phase 2, since Nov 17, 20253 company-led studies, 3 open or runningNext primary completion: Jun 1, 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Prana Therapies33 open or runningphase 2since Nov 17, 2025Nov 17, 2025Jun 1, 2027phase 2 · NCT07730281

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 17, 2025First study: phase 2 study in AsthmaFirst studyNCT07245368 · 96 planned · Australia, New Zealand
  2. Jul 23, 2026Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT07730281 · 40 planned · Australia
  3. Sep 3, 2026Phase 2 study in Dermatitis, AtopicNCT07810777 · 39 planned · Australia, New Zealand

Ahead

  1. Jun 1, 2027Primary completion: phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT07730281
  2. Sep 30, 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07810777

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07810777Dermatitis, Atopic · Australia, New Zealand2RecruitingSep 30, 202739
NCT07730281Pulmonary Disease, Chronic Obstructive · Australia2RecruitingJun 1, 202740
NCT07245368Asthma · Australia, New Zealand2RecruitingOct 1, 202696

How it is read

Names in the registry

  • “PRA-216”, 2 entries
  • “Active PRA-216”, 1 entry

Codes read as this program: PRA216.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.